Literature DB >> 23966338

Rectal douching and implications for rectal microbicides among populations vulnerable to HIV in South America: a qualitative study.

Jerome T Galea1, Janni J Kinsler, John Imrie, César R Nureña, Jorge Sánchez, William E Cunningham.   

Abstract

OBJECTIVE: While gel-formulated rectal microbicides (RM) are the first to enter clinical trials, rectal douching in preparation for anal intercourse is a common practice; thus RMs formulated as douches may be a convenient alternative to gels. Nonetheless, little is known about potential users' thoughts regarding douche-formulated RMs or rectal douching practices, data that is needed to inform the advancement of douche-based RMs. This qualitative study examined thoughts regarding douches, their use as an RM and current douching practices among men who have sex with men and transgender women.
METHODS: 12 focus groups and 36 in-depth interviews were conducted (N=140) to examine the overall acceptability of RM, of which one component focused on rectal douching. Focus groups and interviews were recorded, transcribed verbatim and coded; text relating to rectal douching was extracted and analysed. Sociodemographic information was collected using a self-administered questionnaire.
RESULTS: Support for a douche-formulated RM centred on the possibility of combined precoital hygiene and HIV protection, and it was believed that a deeply penetrating liquid douche would confer greater HIV protection than a gel. Drawbacks included rectal dryness, impracticality and portability issues, and potential side effects. Non-commercial douching apparatus use was common and liquids used included detergents, vinegar, bleach, lemon juice and alcohol.
CONCLUSIONS: A douche-formulated RM, while desirable and perceived as more effective than a gel-formulated RM, also generated questions regarding practicality and side effects. Of immediate concern were the non-commercial liquids already being used that likely damage rectal epithelia, potentially increasing HIV infection risk. Precoital rectal douching is common and an RM formulated as such is desirable, but education on rectal douching practices is needed now.

Entities:  

Keywords:  GAY MEN; HIV; MICROBICIDES; PREVENTION

Mesh:

Substances:

Year:  2013        PMID: 23966338      PMCID: PMC4035233          DOI: 10.1136/sextrans-2013-051154

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  8 in total

1.  Frequent use of lubricants for anal sex among men who have sex with men: the HIV prevention potential of a microbicidal gel.

Authors:  A Carballo-Diéguez; Z Stein; H Sáez; C Dolezal; L Nieves-Rosa; F Díaz
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

2.  Rectal douching among Peruvian men who have sex with men, and acceptability of a douche-formulated rectal microbicide to prevent HIV infection.

Authors:  Janni J Kinsler; Jerome T Galea; Javier R Lama; Patricia Segura; Jesús Peinado; Martin Casapia; Abner Ortiz; Carsten Nadjat-Haiem; Silvia M Montano; Jorge Sanchez
Journal:  Sex Transm Infect       Date:  2012-07-06       Impact factor: 3.519

3.  Lubricant use among men who have sex with men reporting receptive anal intercourse in Peru: implications for rectal microbicides as an HIV prevention strategy.

Authors:  J J Kinsler; J T Galea; J Peinado; P Segura; S M Montano; J Sánchez
Journal:  Int J STD AIDS       Date:  2010-08       Impact factor: 1.359

Review 4.  Global epidemiology of HIV infection in men who have sex with men.

Authors:  Chris Beyrer; Stefan D Baral; Frits van Griensven; Steven M Goodreau; Suwat Chariyalertsak; Andrea L Wirtz; Ron Brookmeyer
Journal:  Lancet       Date:  2012-07-20       Impact factor: 79.321

5.  Why rectal douches may be acceptable rectal-microbicide delivery vehicles for men who have sex with men.

Authors:  Alex Carballo-Diéguez; José Bauermeister; Ana Ventuneac; Curtis Dolezal; Kenneth Mayer
Journal:  Sex Transm Dis       Date:  2010-04       Impact factor: 2.830

6.  The use of rectal douches among HIV-uninfected and infected men who have unprotected receptive anal intercourse: implications for rectal microbicides.

Authors:  Alex Carballo-Diéguez; José A Bauermeister; Ana Ventuneac; Curtis Dolezal; Ivan Balan; Robert H Remien
Journal:  AIDS Behav       Date:  2007-08-18

7.  Acceptability of potential rectal microbicide delivery systems for HIV prevention: a randomized crossover trial.

Authors:  Heather A Pines; Pamina M Gorbach; Robert E Weiss; Kristen Hess; Ryan Murphy; Terry Saunders; Joelle Brown; Peter A Anton; Ross D Cranston
Journal:  AIDS Behav       Date:  2013-03

Review 8.  Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000-2006: a systematic review.

Authors:  Stefan Baral; Frangiscos Sifakis; Farley Cleghorn; Chris Beyrer
Journal:  PLoS Med       Date:  2007-12       Impact factor: 11.069

  8 in total
  11 in total

1.  Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV Infection.

Authors:  Peng Xiao; Sanjeev Gumber; Mark A Marzinke; Abhijit A Date; Thuy Hoang; Justin Hanes; Laura M Ensign; Lin Wang; Lisa Rohan; Edward J Fuchs; Craig Hendrix; Francois Villinger
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  Rectal Douching Practices Associated with Anal Intercourse: Implications for the Development of a Behaviorally Congruent HIV-Prevention Rectal Microbicide Douche.

Authors:  Alex Carballo-Dieguez; Rebecca Giguere; Cody Lentz; Curtis Dolezal; Edward J Fuchs; Craig W Hendrix
Journal:  AIDS Behav       Date:  2019-06

Review 3.  Rectal Douching Associated with Receptive Anal Intercourse: A Literature Review.

Authors:  Alex Carballo-Diéguez; Cody Lentz; Rebecca Giguere; Edward J Fuchs; Craig W Hendrix
Journal:  AIDS Behav       Date:  2018-04

Review 4.  On-demand microbicide products: design matters.

Authors:  Sravan Kumar Patel; Lisa Cencia Rohan
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

5.  Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

Authors:  Alex Carballo-Diéguez; Rebecca Giguere; Curtis Dolezal; Cheng-Shiun Leu; Iván C Balán; William Brown; Christine Rael; Barbra A Richardson; Jeanna M Piper; Linda-Gail Bekker; Suwat Chariyalertsak; Anupong Chitwarakorn; Pedro Gonzales; Timothy H Holtz; Albert Liu; Kenneth H Mayer; Carmen D Zorrilla; Javier R Lama; Ian McGowan; Ross D Cranston
Journal:  AIDS Behav       Date:  2017-12

6.  Anal Douche Practices and Willingness to Use a Rectal Microbicide Enema for HIV Prevention and Associated Factors Among an Internet Sample of HIV-Negative and HIV-Discordant Male Couples in the US.

Authors:  Jason W Mitchell; Amber I Sophus; Ji-Young Lee; Andrew E Petroll
Journal:  AIDS Behav       Date:  2016-11

7.  Lessons for Rectal Microbicide Development From an Acceptability Trial of a Placebo Gel Applied Prior to Receptive Anal Intercourse.

Authors:  Timothy Frasca; Rebecca Giguere; Mobolaji Ibitoye; Curtis Dolezal; Irma Febo; Ross D Cranston; Kenneth Mayer; Ian McGowan; Alex Carballo-Diéguez
Journal:  Arch Sex Behav       Date:  2016-04-29

8.  Rectal Douching Among Men Who Have Sex with Men in Paris: Implications for HIV/STI Risk Behaviors and Rectal Microbicide Development.

Authors:  H Rhodes Hambrick; Su Hyun Park; William C Goedel; Jace G Morganstein; Noah T Kreski; Ofole Mgbako; Dustin T Duncan
Journal:  AIDS Behav       Date:  2018-02

9.  Prevalence and types of rectal douches used for anal intercourse among men who have sex with men in Brazil.

Authors:  Luiz Carlos Ribeiro Lamblet; Roberto José Carvalho da Silva
Journal:  BMJ Open       Date:  2017-05-29       Impact factor: 2.692

10.  Prevalence and types of rectal douches used for anal intercourse: results from an international survey.

Authors:  Marjan Javanbakht; Shauna Stahlman; Jim Pickett; Marc-André LeBlanc; Pamina M Gorbach
Journal:  BMC Infect Dis       Date:  2014-02-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.